Soker S, Takashima S, Miao HQ, Neufeld G and Klagsbrun M.(1998)"Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor."Cell.92,735-45. PMID9529250
Fong GH, Zhang L, Bryce DM and Peng J.(1999)"Increased hemangioblast commitment, not vascular disorganization, is the primary defect in flt-1 knock-out mice."Development.126,3025-35. PMID10357944
Keyt BA, Nguyen HV, Berleau LT, Duarte CM, Park J, Chen H and Ferrara N.(1996)"Identification of vascular
endothelial growth factor determinants for binding KDR and FLT-1 receptors. Generation of
receptor-selective VEGF variants by site-directed mutagenesis."J.Biol.Chem.271,5638-46. PMID8621427
Shalaby F, Rossant J, Yamaguchi TP, Gertsenstein M, Wu XF, Breitman ML and Schuh AC.(1995)"Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice."Nature.376,62-6. PMID7596435
Takahashi T and Shibuya M.(1997)"The 230 kDa mature form of KDR/Flk-1 (VEGF receptor-2) activates the PLC-gamma pathway and partially induces mitotic signals in NIH3T3 fibroblasts."Nature.14,2079-89. PMID9160888
Karkkainen MJ, Haiko P, Sainio K, Partanen J, Taipale J, Petrova TV, Jeltsch M, Jackson DG, Talikka M, Rauvala H, Betsholtz C and Alitalo K.(2004)"Vascular endothelial growth factor C is required for sprouting of the first lymphatic vessels from embryonic veins."Nat.Immunol.5,74-80. PMID14634646
Roberts N, Kloos B, Cassella M, Podgrabinska S, Persaud K, Wu Y, Pytowski B and Skobe M.(2006)"Inhibition of VEGFR-3 activation with the antagonistic antibody more potently suppresses lymph node and distant metastases than inactivation of VEGFR-2."Cancer.Res.66,2650-7. PMID16510584
Goldman CK, Kendall RL, Cabrera G, Soroceanu L, Heike Y, Gillespie GY, Siegal GP, Mao X, Bett AJ, Huckle WR, Thomas KA and Curiel DT.(1998)"Paracrine expression of a native soluble vascular endothelial growth factor receptor inhibits tumor growth, metastasis, and mortality rate."Proc.Natl.Acad.Sci.USA.95,8795-880. PMID9671758
